Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05083741 · ClinicalTrials.gov registry record
Comparison of Chitodex Gel Vs NexFoam on Post-operative Outcomes in the Treatment of Chronic Rhinosinusitis
A clinical trial, sponsored by St. Louis University.
- Terminated
- Registry status
- 7
- Enrollment target
NCT05083741 is a clinical trial that was terminated before completion, run by St. Louis University. The registered enrollment target is 7 participants.
The verdict
NCT05083741 was terminated before completion, sponsored by St. Louis University.
- TERMINATED
- Registry status
- 7 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the efficacy and outcomes of Chitodex gel plus Kenalog versus Nexfoam plus Kenalog in patients with chronic rhinosinusitis (CRS) undergoing sinus surgery. Both dressings are already known to be beneficial in controlling postoperative bleeding and promote wound healing.
Interventions
- DEVICE Chitogel
- DEVICE Nexfoam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2021-12-27 |
| Est. Completion | 2024-08-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05083741
The ClinicalTrials.gov registry entry for NCT05083741 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Louis University, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Chitogel is the first listed.
NCT05083741 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05083741 about?
NCT05083741 is a clinical study titled "Comparison of Chitodex Gel Vs NexFoam on Post-operative Outcomes in the Treatment of Chronic Rhinosinusitis". The purpose of this study is to compare the efficacy and outcomes of Chitodex gel plus Kenalog versus Nexfoam plus Kenalog in patients with chronic rhinosinusitis (CRS) undergoing sinus surgery. Both dressings are already known to be beneficial in controlling postoperative bleeding and promote wound...
What is the current status of trial NCT05083741?
This trial is currently terminated. The enrollment target is 7 participants. The study started on 2021-12-27. Estimated completion is 2024-08-08.
What interventions are being tested in trial NCT05083741?
The interventions under investigation include: Chitogel (DEVICE), Nexfoam (DEVICE).
Who is sponsoring clinical trial NCT05083741?
This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.